Bright Run funded projects

BRIGHT provided funding to support a phase II randomized trial to evaluate the safety of two accelerated partial breast irradiation regimens, of different intensities, in women who had undergone lumpectomy for breast cancer. Sixty-two women were enrolled in Hamilton...

Approximately 30% of women who present with early breast cancer undergo mastectomy. The results of randomized clinical trials have shown that post mastectomy radiotherapy {PMRT} (radiation to the chest wall, nodes in the neck and nodes under the arm) reduces the risk...

Hereditary breast cancer accounts for 5-10% of all breast cancer diagnoses and is primarily caused by changes (mutations) in two genes called BRCA1 and BRCA2. Female relatives found to carry a familial BRCA1/2 mutation are at high risk to develop breast and ovarian...

Imaging of the breast is an important tool in the early detection, diagnosis and monitoring of response to treatment in breast cancer. Mammography has been the gold standard for detection of breast cancer for many years. Mammographic findings are based on anatomic...

One in eight women will develop breast cancer in their lifetime. With improved screening and treatment techniques, more women are surviving breast cancer. However, women live with physical and emotional side effects for years after cancer treatments have ended....